Quantcast
Last updated on April 17, 2014 at 9:08 EDT

Latest Myriad Genetics Stories

2014-02-05 04:21:59

DUBLIN, February 5, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3vvhng/global) has announced the addition of the "Global Personalized Medicine Diagnostics Market - Forecasts to 2016" [http://www.researchandmarkets.com/research/3vvhng/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) One of the main trends witnessed in the Global Personalized Medicine Diagnostics market is the...

2013-11-04 23:18:49

Reportbuyer.com just published a new market research report: Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis. London (PRWEB) November 04, 2013 Global Molecular Diagnostics Market & Future Forecast to 2017 Overview The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness...

2013-10-09 12:27:20

American Cancer Society CMO, Supreme Court Plaintiff Warn of Consumer Risks PLAINSBORO, N.J., Oct. 9, 2013 /PRNewswire/ -- Genetic testing is on the rise, but consumers who order tests without genetic counseling or purchase test kits off the Internet may put themselves at risk. Those risks can range from having the wrong test ordered or the result misinterpreted, or even having prophylactic surgery that turns out to be unnecessary. This was the consensus of a panel that featured some of the...

2013-10-07 23:18:13

Reportbuyer.com just published a new market research report: Therapies and Diagnostics for Ovarian Cancer. London (PRWEB) October 07, 2013 STUDY GOALS AND OBJECTIVES This report, Therapies and Diagnostics for Ovarian Cancer, provides an overview of the current and potential global market for ovarian cancer and treatments and testing technologies. The report provides comprehensive information on ovarian cancer and highlights treatment guidelines. It identifies and analyses the key trends...

2013-10-02 23:22:13

Reportbuyer.com just published a new market research report: Genetic Testing Market Outlook to 2017. London (PRWEB) October 02, 2013 A recent report, “Genetic Testing Market Outlook to 2017”, provides an in-depth analysis of the current and future genetic testing market. A comprehensive introduction of gene-based tests, their working principles and types are covered in around a 140-page report. On account of our analysis of the past and present market trends; drivers; and existing...

2013-08-15 08:29:35

-- Will continue to offer fast, accurate, and affordable alternative for BRCA1/2 testing -- HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics. Both companies are also countersuing Myriad for violations of the Federal Antitrust Act. On June 13, 2013,...

2013-07-01 12:27:35

WASHINGTON, July 1, 2013 /PRNewswire/ -- AACC is pleased to announce the addition of a late-breaking session, The Supreme Court Decision on Human Gene Patents and Its Implications, to its scientific program at the 2013 AACC Annual Meeting & Clinical Lab Expo in Houston. (Logo: http://photos.prnewswire.com/prnh/20130701/PH41045LOGO) On June 13, the Supreme Court ruled that genes isolated from human DNA cannot be patented because they are "products of nature," but that...

2013-06-19 12:27:39

Media are Invited to Register Now For a Live, CAP-Exclusive Event WASHINGTON, June 19, 2013 /PRNewswire-USNewswire/ -- Genomic medicine has the potential to be a cornerstone of medical testing, treatment, and clinical integration. Without doubt, the Supreme Court's unanimous decision invalidating Myriad's patents on BRCA1 and BRCA2 is already changing the testing landscape for those genes. What other changes can we expect? How will the decision impact medical testing? What did it...

2013-06-18 23:03:27

The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry reliance on the Patent Office´s grant of more than 3,000 patents over 30 years to a footnote for Congressional action. (PRWEB) June 18, 2013 The Supreme Court recently gave its answer of “No” to the question of whether human genes were patent-eligible subject matter. The decision relegates industry...

2013-06-13 23:03:37

Plaintiffs, including the American Civil Liberties Union, Association for Molecular Pathology, and American Society for Clinical Pathology, win long-fought case against Myriad Genetics, Association for Molecular Pathology v. Myriad Genetics, Inc. No. 12—398, that has far-reaching possibilities for genetic research and improved patient outcomes. Chicago, IL (PRWEB) June 13, 2013 The U.S. Supreme Court today invalidated patents on two genes associated with hereditary breast and ovarian...